Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Genera… Read more
Nexalin Technology Inc. (NXL) - Total Assets
Latest total assets as of September 2025: $5.13 Million USD
Based on the latest financial reports, Nexalin Technology Inc. (NXL) holds total assets worth $5.13 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nexalin Technology Inc. - Total Assets Trend (2019–2024)
This chart illustrates how Nexalin Technology Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Nexalin Technology Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Nexalin Technology Inc.'s total assets of $5.13 Million consist of 93.8% current assets and 6.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 13.6% |
| Accounts Receivable | $13.04K | 0.3% |
| Inventory | $174.58K | 4.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $260.73K | 6.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2024)
This chart illustrates how Nexalin Technology Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nexalin Technology Inc.'s current assets represent 93.8% of total assets in 2024, a decrease from 98.8% in 2019.
- Cash Position: Cash and equivalents constituted 13.6% of total assets in 2024, down from 56.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 6.2% of total assets.
Nexalin Technology Inc. Competitors by Total Assets
Key competitors of Nexalin Technology Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Nexalin Technology Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Nexalin Technology Inc. generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Nexalin Technology Inc. is currently not profitable relative to its asset base.
Nexalin Technology Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 13.47 | 16.39 | 0.07 |
| Quick Ratio | 13.03 | 15.86 | 0.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.46 Million | $ 4.61 Million | $ -1.45 Million |
Nexalin Technology Inc. - Advanced Valuation Insights
This section examines the relationship between Nexalin Technology Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.73 |
| Latest Market Cap to Assets Ratio | 1.54 |
| Asset Growth Rate (YoY) | 16.3% |
| Total Assets | $4.22 Million |
| Market Capitalization | $6.52 Million USD |
Valuation Analysis
Above Book Valuation: The market values Nexalin Technology Inc.'s assets above their book value (1.54 x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Nexalin Technology Inc.'s assets grew by 16.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nexalin Technology Inc. (2019–2024)
The table below shows the annual total assets of Nexalin Technology Inc. from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.22 Million | +16.27% |
| 2023-12-31 | $3.63 Million | -51.13% |
| 2022-12-31 | $7.43 Million | +886.09% |
| 2021-12-31 | $753.70K | +536.24% |
| 2020-12-31 | $118.46K | +5.29% |
| 2019-12-31 | $112.51K | -- |